Olutasidenib - HY-114226
Nur noch %1 verfügbar
Catalog #
HY-114226
Ab
217,00 €
Olutasidenib (FT-2102) is a highly potent, orally active, brain penetrant and selective inhibitor of mutant Isocitrate dehydrogenase 1 (IDH1), with IC50 values of 21.2 nM and 114 nM for IDH1- R132H and IDH1- R132C, respectively . Olutasidenib (FT-2102) is under the study in the treatment of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) [1][2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-114226/Olutasidenib-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-programmed cell death |
| Alternative Names | FT-2102 |
| CAS | 1887014-12-1 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 354.79 |
| Solubility | DMSO : 125 mg/mL (ultrasonic) |
| Clinical Information | Launched |
| Target | Isocitrate Dehydrogenase (IDH) |
| Application: | Cancer-programmed cell death |
|---|